Average Co-Inventor Count = 10.20
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (19 from 3,237 patents)
2. Array Biopharma Inc. (5 from 329 patents)
3. Constellation Pharmaceuticals, Inc. (4 from 55 patents)
4. F. Hoffmann-La Roche Ag (2 from 169 patents)
5. Maze Therapeutics, Inc. (2 from 3 patents)
6. Xenon Pharmaceuticals Inc. (1 from 109 patents)
7. Covenentech, Inc. (1 from 1 patent)
8. Hoffman-Laroche, Inc. (US Only) (1 from 1 patent)
9. F. Hoffman-Laroche, Ag (Ex-US) (1 from 1 patent)
24 patents:
1. 12344610 - APOL1 inhibitors and methods of use
2. 12233052 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
3. 12139496 - Therapeutic compounds and methods of use thereof
4. 11976067 - APOL1 inhibitors and methods of use
5. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
6. 10947251 - Therapeutic compounds and methods of use thereof
7. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof
8. 10457654 - Therapeutic compounds and methods of use thereof
9. 10280149 - Therapeutic compounds and uses thereof
10. 10053451 - Heterocyclic estrogen receptor modulators and uses thereof
11. 10035801 - Pyrazolo compounds and uses thereof
12. 10022354 - Pyrrolidine amide compounds as histone demethylase inhibitors
13. 9980947 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
14. 9969732 - Tetrahydroisoquinoline estrogen receptor modulators and uses thereof
15. 9505767 - Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors